NCT00923572View on ClinicalTrials.gov

Yasmin Post Marketing Surveillance

CompletedOBSERVATIONAL
Enrollment

777

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

May 31, 2013

Study Completion Date

August 31, 2013

Conditions
Contraception
Interventions
DRUG

EE30/DRSP (Yasmin, BAY86-5131)

Patients in daily life clinical practice treatment receiving Yasmin according to indication on the label.

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00923572 - Yasmin Post Marketing Surveillance | Biotech Hunter | Biotech Hunter